Stock comparison
Geron
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GERN
Geron
Market cap
$789.07M
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GERN | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 36D | 77B | LMAT |
| Benjamin Graham | 63D | 89A | LMAT |
| Philip Fisher | 52C | 81C | LMAT |
| Peter Lynch | 20F | 67B | LMAT |
| Joel Greenblatt | 2F | 56D | LMAT |
| Charlie Munger | 43D | 68D | LMAT |
| Terry Smith | 48D | 69D | LMAT |
Side-by-side metrics
| Metric | GERN | LMAT |
|---|---|---|
| Market cap | $789.07M | $2.32B |
| P/E (TTM) | - | 37.1x |
| EV/EBIT | - | 36.6x |
| ROIC (TTM) | -7.77% | 9.43% |
| Gross margin | 86.59% | 72.39% |
| Net margin | -35.48% | 24.35% |
| Revenue CAGR 5y | 2.39% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 1.1x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GERN leads on
- EV/EBIT-vs 36.6x+149%
- P/E (TTM)-vs 37.1x+132%
- Revenue CAGR 5y2.39%vs 12.75%+95%
- Gross margin86.59%vs 72.39%+16%
LMAT leads on
- ROIC (TTM)9.43%vs -7.77%+182%
- Net margin24.35%vs -35.48%+169%
- Dividend yield0.84%vs 0.0%+100%
- Market cap$2.32Bvs $789.07M+66%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.